MX9701841A - Derivados aminoheterociclicos como agentes antitromboticos o anticoagulantes. - Google Patents

Derivados aminoheterociclicos como agentes antitromboticos o anticoagulantes.

Info

Publication number
MX9701841A
MX9701841A MX9701841A MX9701841A MX9701841A MX 9701841 A MX9701841 A MX 9701841A MX 9701841 A MX9701841 A MX 9701841A MX 9701841 A MX9701841 A MX 9701841A MX 9701841 A MX9701841 A MX 9701841A
Authority
MX
Mexico
Prior art keywords
antithrombotic
alkylene
anticoagulant agents
group
formula
Prior art date
Application number
MX9701841A
Other languages
English (en)
Other versions
MXPA97001841A (es
Inventor
Alan Wellington Faull
Colette Marie Mayo
John Preston
Andrew Stocker
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9419341A external-priority patent/GB9419341D0/en
Priority claimed from GBGB9425789.6A external-priority patent/GB9425789D0/en
Priority claimed from GBGB9511051.6A external-priority patent/GB9511051D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of MX9701841A publication Critical patent/MX9701841A/es
Publication of MXPA97001841A publication Critical patent/MXPA97001841A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

La invencion se relaciona con compuestos de la formula (I), en el que cada uno de G1, G2 y G3 es CH o Ni; m es 1 o 2; R1 incluye hidrogeno, halogeno y alquilo de C1-4; M1 es un grupo de la formula: NR2-L1-T1r., en el cual R2 y R3 juntos forman un grupo alquileno de C1-4 y T1 es CH o N; A puede ser un enlace directo; M2 es un grupo de la formula: (T2R4)r-L2-T3R5 en el cual R es 0 o 1, cada uno de T2 y T?? es CH o N, cada uno de R4 y r5 es hidrogeno o alquilo de C1-4 o R4 y R5 juntos forman un grupo alquileno de C1-4 y L2 incluye alquileno de C4; M puede ser un enlace directo con X; X incluye sulfonilo; y Q incluye naftilo y una porcion heterocíclica; o su sal farmacéuticamente aceptable; proceso para su preparacion, composiciones farmecéuticas que los contienen y cu uso como agentes antitromboticos y anticoagulantes.
MXPA/A/1997/001841A 1994-09-26 1997-03-11 Derivados aminoheterociclicos como agentes antitromboticos o anticoagulantes MXPA97001841A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9419341.4 1994-09-26
GB9419341A GB9419341D0 (en) 1994-09-26 1994-09-26 Aminoheterocyclic derivatives
GBGB9425789.6A GB9425789D0 (en) 1994-12-21 1994-12-21 Aminoheterocyclic derivatives
GB9425789.6 1994-12-21
GB9511051.6 1995-06-01
GBGB9511051.6A GB9511051D0 (en) 1995-06-01 1995-06-01 Aminoheterocyclic derivatives

Publications (2)

Publication Number Publication Date
MX9701841A true MX9701841A (es) 1998-10-31
MXPA97001841A MXPA97001841A (es) 1999-01-11

Family

ID=

Also Published As

Publication number Publication date
EP0783500B1 (en) 1998-07-22
JPH10506122A (ja) 1998-06-16
US20020119968A1 (en) 2002-08-29
BR9509045A (pt) 1997-09-30
DK0783500T3 (da) 1999-04-26
NO971415L (no) 1997-05-22
AU696491B2 (en) 1998-09-10
US6730672B2 (en) 2004-05-04
CZ89397A3 (en) 1997-07-16
SK38597A3 (en) 1997-09-10
US5965559A (en) 1999-10-12
AU3530795A (en) 1996-04-19
NO971415D0 (no) 1997-03-25
ES2119472T3 (es) 1998-10-01
ATE168685T1 (de) 1998-08-15
IL115420A0 (en) 1995-12-31
DE69503647D1 (de) 1998-08-27
CZ285370B6 (cs) 1999-07-14
CA2197471A1 (en) 1996-04-04
HUT77769A (hu) 1998-08-28
EP0783500A1 (en) 1997-07-16
DE69503647T2 (de) 1999-01-14
US6225309B1 (en) 2001-05-01
NZ292983A (en) 1998-12-23
PL319430A1 (en) 1997-08-04
WO1996010022A1 (en) 1996-04-04

Similar Documents

Publication Publication Date Title
IL115420A0 (en) Aminoheterocyclic derivatives
ES8401032A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas.
ES2091212T3 (es) Compuestos de xantina.
DK599785D0 (da) Blokpolyestere og detergentkompositioner indeholdende disse
MY109937A (en) Substituted azoles, processes for the preparation thereof, agents containing these, and the use thereof.
ES8700672A1 (es) Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos.
MY101748A (en) Novel 8-chloro-1, 5-benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions.
IL69292A (en) Muramyl peptides substituted by 1,2-diacylated-sn-glycero-3-hydroxyphosphoryl,their manufacture and pharmaceutical compositions containing them
DK283984A (da) Benzodiazepinderivater og fremgangsmaade til fremstilling deraf
ES8604721A1 (es) Un procedimiento para la preparacion de derivados de piperi-dina
MX9702089A (es) Carboxamidas biciclicas como antagonistas de 5-ht1a.
TW329388B (en) Intraocular irrigating solution
HK1004546A1 (en) Aminoalcohols useful as optical resolving agents